common.study.topics.clinical

Identifying High-Risk Breast Cancer Patients

common.study.values.description

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - Magnetic Resonance Imaging

Undergo high risk breast cancer screening MRI

Procedure - Biospecimen Collection

Undergo blood and tissue sample collection

Laboratory Biomarker Analysis

Correlative studies

participant.views.study.view.additional

participant.views.study.view.scientific-title

Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology

common.study.values.clinical-trial-id

NCT03303846

participant.views.study.view.id

Le3Nrd